JLABS @TMC has taken a Texas sized approach to our JLABS' Meet with... Series by bringing three early stage investors to Houston for one-on-one meetings with emerging healthcare companies. The firms, including Allegory Ventures, Azimuth Ventures and Johnson & Johnson Innovation - JJDC, represent corporate, angel and traditional venture models hailing from California, Texas and New York. The speakers will participate in a series of presentations led by the Houston Angel Network and discuss their firms' key areas of interest, trends and best practices when seeking funding.
Following the presentation, don't miss this opportunity to network with fellow attendees and the panelists during lunch. Finally, for those companies who apply online and receive approval, Allegory, Azimuth, and JJDC will be on hand to meet one-on-one with selected applicants.
10:30 AM | Registration Opens, Networking session
11:00 AM | Presentation and Q&A
11:50 AM | Networking Lunch
12:30 PM | One-on-one Meetings*
5:00 PM | Program Close
*Companies must apply for a one-on-one meeting ahead of time and be approved. The application period ends on September 5th.
Milena Adamian | Founder and Managing Partner, Azimuth Ventures/Life Science Angel Network read bio»
Thomas DeSouza | Managing Partner, Allegory Venture Partners read bio»
Renee Compton Ryan | Vice President, Venture Investments, Johnson & Johnson Innovation - JJDC read bio»
Robert Tucci | Co-Chair, Sciences and Life Sciences, Houston Angel Network [Moderator]read bio»
About Azimuth Ventures:
Azimuth Ventures (Azimuth) is based in New York City and focused on early stage opportunities improving access and delivery of healthcare through technology-enabled solutions with tangible impact on clinical or efficacy outcomes. Insights are from Azimuth's predecessor, Life Science Angel Network (LSAN) and are applying experiences gained there to a larger investment scale. Azimuth is interested in meeting technology enabled solutions (services, analytics, and workflow), personalized medicine solutions, medical devices and diagnostics. (apply here)
Azimuth's Participating Representative: Milena Adamian | Founder and Managing Partner, Azimuth Ventures/Life Science Angel Network
Dr. Adamian is a Managing Partner of Azimuth Ventures, a venture fund focused on early stage healthcare-centric opportunities. She is also the Founder and Executive Director of Life Sciences Angel Network (predecessor of Azimuth Ventures) focused on the early stage investing in medical devices, healthcare information technology and services as well as educational activities for entrepreneurs and investors. Milena brings unique perspective of a clinician and academic researcher with genuine passion for breakthrough technologies enriched by industry knowledge, Wall Street, and venture capital experience. In last 20 years, her career included professional appointments at Interventional Cardiology department (Lenox Hill Hospital (NYC) and Columbus Hospital (Milan, Italy), Medical Director at Boston Scientific Corporation (NYSE: BSC), Equity analyst (Medical Devices and Supplies) at Lehman Brothers and Managing Director, Easton Capital. Dr. Adamian's past and present investments and board involvements include Xoft (now NYSE: ICAD), Cardiovascular Systems (now NYSE: CSII), Forge Medical, Precise Light Surgical, Quartzy, Comprehend Systems, ZappRX, Common Sensing, BioTrace Medical, Wellframe, Owlet Care, and Lifecode Health. Milena is actively involved in a number of accelerators and angel groups across the US. Milena Adamian was named to the TechWeek100 list of leaders in NYC area with significant impact in business and technology and was named among 2014 - Women of Influence Honoree 2015 by New York Business Journal. Dr. Adamian is a member of the American College of Cardiology and is also an author of a number of scientific peer-reviewed papers. She holds an MSc degree in Biostatistics and Clinical Research Methods from Mailman School of Public Health at Columbia University, and M.D. and Ph.D. degrees in Clinical Cardiology from the Russian Academy of Medical Sciences.
Connect with Milena:
About Allegory Venture Partners:
Allegory Ventures Partners (Allegory) is life sciences focused venture capital firm based in Houston, Texas and Portland, Oregon. Funded through a collaboration with Oregon Health Science University (OHSU), Allegory receives financial support from the University, as well as opportunity to examine new technologies arising from OHSU research programs which are catalyzed by the recent $1B Knight Challenge. Allegory Ventures is interested in meeting digital health/health IT, healthcare services, medical devices and diagnostics and research tools and technologies. (apply here)
Allegory's Participating Representative: Thomas DeSouza | Managing Partner, Allegory Venture Partners
Thomas has been working with entrepreneurs and allocating capital to promising companies for over a decade. Having founded multiple start-ups and working with management of many exciting young companies, Thomas is no stranger to the issues that early stage companies face. Prior to Allegory, Thomas was a partner of the DeSouza Perez Group at Robert W. Baird & Co. He joined Baird after his time at Morgan Stanley as a Portfolio Manager. Thomas is a Board Director of SemanticMD. Thomas attended Portland State University with degrees in Finance and Political Science. He has been responsible for the development of two non-profit organizations within the last six years. He is an active member in the Keiretsu forum where he is a member of the life sciences sub-committee. Thomas also serves on the Board of Directors and Investment Committee for Willamette View Foundation.
Connect with Thomas:
About Johnson & Johnson Innovation - JJDC:
As the oldest corporate venture fund in the life science industry, Johnson & Johnson Innovation - JJDC has been making strategic investments in life science innovations for over 40 years. JJDC has invested and funded hundreds of emerging life science companies developing health care solutions in the areas of strategic interest to the Johnson & Johnson Family of Companies and plays a key role in the company's strategy to bring new healthcare products to the people who need them. JJDC is interested in meeting medical device and consumer medical device companies. (apply here)
JJDC's Participating Representative: Renee Compton Ryan | Vice President, Venture Investments, Johnson & Johnson Innovation - JJDC
Renee Compton Ryan joined Johnson & Johnson Innovation - JJDC, Inc. (JJDC) in 2011. She is based in Silicon Valley, California and primarily supports the strategic investment activities in medical devices and diagnostics. Mrs. Ryan's background includes over 20 years of healthcare investment banking. Most recently, she ran the medical device investment banking effort at R.W. Baird & Co. Previously, she lead the West Coast medical device group at Jefferies & Co. and was in the healthcare investment banking groups at Goldman Sachs and Credit Suisse. Mrs. Ryan received an MBA from Columbia Business School and a Bachelors degree from Georgetown University.
Connect with Renee:
Robert Tucci | Co-Chair, Sciences and Life Sciences, Houston Angel Network
Rob is an active investor and eight year member, board member, and Life Sciences Chair at the Houston Angel Network. He is a member of the University of Houston's Cougar Fund, serving as a judge and has lectured in the Bauer School of Business. At the $6.5M Texas Halo Fund, Rob serves on the managing Board of Directors and directs investments generally within the biotechnology, life sciences and energy sectors. He is the founder (1996) of Yardley Group, LLC, an active chemical development and export business serving South America. Rob has served as a judge at the Rice University Business Plan Competition, the world's largest. He is an investment advisor to the University of Texas Horizon Fund, the National Space Biomedical Research Institute, and Molecular Match, Inc. Rob is also on the Board of Directors of Adient Medical, Inc. A degreed chemist and MBA, Rob resides in Houston with his physician wife.
Connect with Rob:
Presentation & Lunch
$25 | General Public
$35 | General Public - at the door
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until September 29th (or full).
FREE | Application
FREE | Accepted Companies
Companies must apply for a one-on-one meeting ahead of time. The one-on-one application period ends on September 5th. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved. All companies accepted for a one-on-one meeting will be notified of acceptance and scheduled meeting time via email.
About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCATS, NINDS, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.
Texas Medical Center
John P. McGovern Campus
2450 Holcombe Blvd, Suite X
Houston, TX 77021
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.
Have questions about Meet with… Early Stage Investors | Multiple tracks for partnering?Contact JLABS @TMC